BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8931667)

  • 1. Adequacy of chemotherapy prior to cytoreductive surgery in testicular carcinoma.
    Kennedy BJ; Torkelson JL; Fraley EE
    Am J Clin Oncol; 1996 Dec; 19(6):541-5. PubMed ID: 8931667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal number of chemotherapy courses in advanced nonseminomatous testicular carcinoma.
    Kennedy BJ; Torkelson J; Fraley EE
    Am J Clin Oncol; 1995 Dec; 18(6):463-8. PubMed ID: 8526185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on "Adequacy of chemotherapy prior to cytoreductive surgery in testicular carcinoma" by B. J. Kennedy, Jane L. Torkelson, and Elwin E. Fraley in this issue pp. 541-545.
    Kagan AR
    Am J Clin Oncol; 1996 Dec; 19(6):636. PubMed ID: 8931688
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of salvage treatment in metastatic testicular teratoma.
    Whillis D; Coleman RE; Cornbleet MA; Howard GC
    Clin Oncol (R Coll Radiol); 1991 May; 3(3):141-6. PubMed ID: 1712626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
    Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
    J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for testicular cancer.
    Xiao H; Sheinfeld J; Motzer RJ
    Surg Oncol Clin N Am; 1997 Oct; 6(4):863-78. PubMed ID: 9309098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
    Broun ER; Nichols CR; Turns M; Williams SD; Loehrer PJ; Roth BJ; Lazarus HM; Einhorn LH
    Cancer; 1994 Mar; 73(6):1716-20. PubMed ID: 7512438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.
    Broun ER; Nichols CR; Gize G; Cornetta K; Hromas RA; Schacht B; Einhorn LH
    Cancer; 1997 Apr; 79(8):1605-10. PubMed ID: 9118046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of testicular cancer in which complete response was achieved with chemotherapy including cisplatin, etoposide and bleomycin, and salvage surgery].
    Uekado Y; Matsumoto M; Inagaki T; Shintani Y
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):543-6. PubMed ID: 7510465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy.
    Gelderman WA; Schraffordt Koops H; Sleijfer DT; Oosterhuis JW; Van der Heide JN; Mulder NH; Marrink J; De Bruyn HW; Oldhoff J
    J Surg Oncol; 1988 Aug; 38(4):227-32. PubMed ID: 2457771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
    Amato RJ; Ro JY; Ayala AG; Swanson DA
    Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of adjuvant chemotherapy in testicular cancer.
    Bernstein JI; Freiha F; Breeden J; Torti FM
    Cancer; 1987 Oct; 60(8):1729-30. PubMed ID: 2443231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of childhood Hodgkin's disease with ABVD without radiotherapy.
    Behrendt H; Brinkhuis M; Van Leeuwen EF
    Med Pediatr Oncol; 1996 Apr; 26(4):244-8. PubMed ID: 8600335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage therapy in recurrent testicular cancer.
    Saxman S
    Semin Oncol; 1992 Apr; 19(2):143-7. PubMed ID: 1372756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Caval involvement in advanced-stage non-seminoma testicular tumors: surgical strategy and long-term results].
    Tavolini IM; Norcen M; Oliva G; Nigro F; Benedetto G; Mazzariol C; Bassi P
    Arch Ital Urol Androl; 2002 Jun; 74(2):69-76. PubMed ID: 12161940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.